IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ZYME

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022
Cash & Equivalents0.180.240.060.100.080.120.070.110.090.140.180.10
Short-term Investments----------------0.200.200.160.07
Accounts Receivable0.010.000.030.000.020.020.030.030.070.050.070.01
Total Current Assets0.300.390.290.300.310.340.380.390.370.420.430.19
Property, Plant & Equipment0.010.010.020.020.020.020.020.020.020.020.020.03
Goodwill0.010.010.010.010.010.010.010.010.010.010.010.01
Intangible Assets0.000.000.000.000.000.010.010.010.010.010.010.01
Total Non-current Assets*0.100.090.110.110.120.140.130.160.180.180.170.11
Total Assets0.400.480.400.410.430.490.520.550.560.600.600.30
Accounts Payable0.030.030.030.030.040.050.040.050.070.070.060.05
Total Current Liabilities0.050.040.040.040.070.080.050.060.070.090.070.06
Total Non-current Liabilities*0.270.280.040.040.040.040.050.060.060.060.060.06
Total Liabilities0.320.310.080.070.100.120.110.120.130.150.130.12
Retained Earnings(1.17)(1.07)(0.89)(0.85)(0.85)(0.80)(0.75)(0.71)(0.66)(0.63)(0.58)(0.87)
Total Stockholder Equity0.080.160.320.330.320.370.410.440.420.450.470.18

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Total Revenue4.592.412.5227.6148.7327.1131.0316.0019.2410.0316.9316.517.0035.58402.492.63
Research & Development------------------32.0425.5232.7839.4145.9152.9737.10
Selling, General & Admin19.3415.0715.4314.1514.9516.9916.1813.8515.6815.7914.8216.9721.7116.9530.1315.89
Operating Income(42.18)(47.12)(44.15)(22.11)(0.67)(25.61)(22.22)(34.20)(42.89)(37.80)(23.42)(33.24)(54.11)(27.28)319.40(50.36)
Pretax Income(45.29)(46.35)(41.48)(18.27)2.13(22.14)(17.79)(29.62)(37.62)(31.58)(19.20)(27.58)(49.50)(22.96)320.44(47.87)
Tax Provision(0.27)(2.19)(0.27)1.34(0.19)0.505.720.230.070.08(4.72)1.111.651.3911.01(0.03)
Net Income(45.02)(44.16)(41.21)(19.60)2.32(22.64)(23.51)(29.85)(37.69)(31.65)(14.48)(28.69)(51.15)(24.35)309.43(47.85)
Basic EPS(0.62)(0.59)(0.55)(0.26)0.03(0.30)(0.32)(0.39)(0.49)(0.42)(0.19)(0.41)(0.76)(0.36)4.77(0.72)
Diluted EPS(0.62)(0.59)(0.55)(0.26)0.03(0.30)(0.32)(0.39)(0.49)(0.42)(0.18)(0.41)(0.76)(0.37)4.76(0.72)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Operating Cash Flow(31.95)(45.72)(10.26)(31.41)12.07(3.41)(41.51)(5.88)(24.99)(37.67)13.95(42.67)(6.40)(83.19)327.36(183.25)
Capital Expenditures0.000.220.580.410.510.020.310.900.590.190.360.930.800.390.357.80
Free Cash Flow*(31.95)(45.93)(10.84)(31.82)11.56(3.42)(41.82)(6.78)(25.58)(37.85)13.60(43.60)(7.20)(83.58)327.01(191.05)
Investing Cash Flow17.0769.965.370.378.7412.18(6.21)72.26(19.97)(7.32)(1.34)(7.02)(60.67)(138.22)(22.06)(31.78)
Financing Cash Flow(50.02)178.79(18.74)(2.45)1.321.32(8.64)(14.98)1.052.1250.611.9027.601.74(0.38)108.96

* Derived from reported values